Loading…

The contextual role of TNFR family members in CD 8 + T‐cell control of viral infections

Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor ( TNF ) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific TNF receptor ( TNFR ) family members in antivira...

Full description

Saved in:
Bibliographic Details
Published in:Immunological reviews 2013-09, Vol.255 (1), p.125-148
Main Authors: Wortzman, Michael E., Clouthier, Derek L., McPherson, Ann J., Lin, Gloria H. Y., Watts, Tania H.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor ( TNF ) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific TNF receptor ( TNFR ) family members in antiviral immunity depends on the stage of the immune response and can vary with the virus type and its virulence. Here, we focus on five members of the TNFR family that are prominently expressed on CD 8 + T cells during viral infections, namely, 4‐1 BB ( CD 137), CD 27, OX 40 ( CD 134), GITR , and TNFR 2. 4‐1 BB , CD 27, OX 40, and GITR have primarily prosurvival roles for CD 8 + T cells during viral infection, although under some circumstances 4‐1 BB , GITR , or CD 27 signals can limit immunity. Although TNFR 2 can be costimulatory under some circumstances, its main role in CD 8 + T‐cell responses during viral infection appears to be in contraction of the response. Several TNF family ligands are being explored as adjuvants for viral vaccines, and agonistic antibodies to TNFR family members are being investigated for immunotherapy of chronic viral infection alone and in combination with checkpoint blockade. Such therapies will require thorough and specific optimization to avoid pathology induced by hyperstimulation of these pathways.
ISSN:0105-2896
1600-065X
DOI:10.1111/imr.12086